gastroparesis, bowel resections), and conditions that could interfere with breath testing accuracy (e.g., lactose intolerance, fructose intolerance) were excluded
Some telehealth companies still offer compounded GLP-1s by using alternative language like GLP-1/GIP protocols or customized formulations. However, these are not FDA-approved and selling them without a documented clinical justification may be considered illegal
The FDA shortage designation for semaglutide and tirzepatide has been resolved, and the FDA has proposed excluding these drugs from the 503B bulks list
Understanding the underlying mechanisms behind Ozempic-related skin reactions helps distinguish between different types of responses and their clinical significance
AOD-9604 Commonly used to support fat metabolism, stubborn fat reduction and body composition optimization, especially abdominal fat
Traditional treatment for these conditions relies on immunosuppressive medications that reduce immune system activity to limit inflammation and prevent tissue damage